MedPath

Pharmaceutical Companies

Dyne Therapeutics logo

Dyne Therapeutics

🇺🇸United States
Ownership
Public
Established
2018-01-01
Employees
141
Market Cap
$4.4B
Website
http://www.dyne-tx.com
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases.  The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for...
Crinetics logo

Crinetics

🇺🇸United States
Ownership
Public
Established
2008-01-01
Employees
290
Market Cap
$4.3B
Website
http://www.crinetics.com
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product...

Galenica AG

🇨🇭Switzerland
Ownership
-
Established
-
Employees
-
Market Cap
$4.3B
Website
-
Axsome Therapeutics logo

Axsome Therapeutics

🇺🇸United States
Ownership
Public
Established
2012-01-01
Employees
545
Market Cap
$4.2B
Website
http://www.axsome.com
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline...
Ownership
Public
Established
1949-01-01
Employees
22.8K
Market Cap
$4.2B
Website
http://www.ipca.com

CRISPR Therapeutics, Inc.

🇺🇸United States
Ownership
Subsidiary
Established
-
Employees
-
Market Cap
$4.1B
Website
-
ADMA Biologics logo

ADMA Biologics

🇺🇸United States
Ownership
Public
Established
2004-01-01
Employees
624
Market Cap
$4B
Website
http://www.admabiologics.com

Perrigo

🇮🇪Ireland
Ownership
Private
Established
-
Employees
9.1K
Market Cap
$3.9B
Website
-
Perrigo Co. Plc engages in the provision of self-care products and over the counter health and wellness solutions. It enhances individual well-being by empowering consumers to proactively prevent or treat conditions that can be...

Biohaven Pharmaceuticals, Inc.

🇺🇸United States
Ownership
Subsidiary
Established
-
Employees
-
Market Cap
$3.9B
Website
-
Arcellx logo

Arcellx

🇺🇸United States
Ownership
Public
Established
2015-01-01
Employees
130
Market Cap
$3.8B
Website
http://www.arcellx.com
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert...
© Copyright 2025. All Rights Reserved by MedPath